Reuters logo
BRIEF-Evotec, Tesaro enter partnership on novel immuno-oncology agents
October 26, 2017 / 5:55 AM / a month ago

BRIEF-Evotec, Tesaro enter partnership on novel immuno-oncology agents

Oct 26 (Reuters) - Evotec Ag

* dgap-news: evotec and tesaro enter strategic partnership to discover novel immuno-oncology agents

* ‍ evotec will apply its integrated drug discovery platform to tesaro’s translational research pipeline to advance best-in-class oncology therapies​

* ‍no financial details of collaboration were disclosed​ Source text for Eikon: Further company coverage:

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below